top of page
Search

๐—ค๐—ฎ๐—ฒ๐—น๐—ผ๐—ป ๐—”๐—ฐ๐—ฐ๐—ฒ๐—ฝ๐˜๐—ฒ๐—ฑ ๐—ถ๐—ป๐˜๐—ผ ๐—ก๐—ฉ๐—œ๐——๐—œ๐—” ๐—œ๐—ป๐—ฐ๐—ฒ๐—ฝ๐˜๐—ถ๐—ผ๐—ป ๐—ฃ๐—ฟ๐—ผ๐—ด๐—ฟ๐—ฎ๐—บ ๐˜๐—ผ ๐—”๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—”๐—œ-๐——๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ป ๐—ฆ๐˜‚๐—ฟ๐—ด๐—ถ๐—ฐ๐—ฎ๐—น ๐—Ÿ๐—ฒ๐—ฎ๐—ธ ๐——๐—ฒ๐˜๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป

Updated: May 5

ree

We are excited to share that Qaelon Medical has been accepted into the @๐—ก๐—ฉ๐—œ๐——๐—œ๐—”ย ๐—œ๐—ป๐—ฐ๐—ฒ๐—ฝ๐˜๐—ถ๐—ผ๐—ปย ๐—ฃ๐—ฟ๐—ผ๐—ด๐—ฟ๐—ฎ๐—บ, a prestigious initiative designed to support startup companies pioneering advancements in ๐—”๐—œย ๐—ฎ๐—ป๐—ฑย ๐—ฑ๐—ฎ๐˜๐—ฎย ๐˜€๐—ฐ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ.


As the first real-time, objective performance indicator (OPI) for surgical leaks, access to NVIDIAโ€™s cutting-edge technologies and global resources will help accelerate Qaelon Medicalโ€™s life-saving mission to reduce surgical leaks using our proprietary data and advanced surgical intelligence. Joining forces with NVIDIA, we are poised to drive transformative impact across the connected surgeryย ecosystem โ€” bringing safer, smarter, and more efficient solutions to the OR.




ย 
ย 
ย 

Recent Posts

See All
Bringing Qaelonโ€™s voice to LSI Europe 2025

CEO, Liam J. Burns, will speak at LSI Europe 2025 in London on the panel: โ€œPre-clinical Perspectives: Navigating the Investor and Regulatory Landscape Before First in Human.โ€

ย 
ย 
ย 

Comments


Note: Qaelon Medical products are currently under development, have not been cleared by the FDA, and are not yet available for commercial sale in the United States or Europe.

Qaelon Medical, IHU, 1 Place de l’Hôpital

67091 Strasbourg, France

Email: yee-ying.douchamps@qaelonmedical.com

  • LinkedIn

© 2025 Qaelon Medical

bottom of page